** Biotech co Exicure Inc's shares XCUR.O drop 12% to
$0.23 after market
** XCUR says there is "substantial doubt" over the co's
ability to continue as a going concern by the end of the year
** "Going concern" refers to a company with stable
financials that is expected to continue doing business in the
foreseeable future
** Co reports 2021 net loss of $64.1 mln vs $24.7 mln loss
in the prior year
** XCUR says expenses on research and development jumped 53%
in the year, while general and administrative costs soared 31%
** Expenses jumped as a result of new hires, severance costs
tied to its December restructuring and higher number of clinical
activities in the year - XCUR
** Says it expects to generate operating losses and negative
operating cash flows in the future, and will continue to need
additional funding
** YTD, shares have gained 54%, as of last close
(Reporting by Niket Nishant in Bengaluru)
((Niket.Nishant@thomsonreuters.com;))